You are attempting to visit a website that NextCell Pharma AB (publ) has established for the publication of documentation and information about its upcoming rights issue. To access additional information, visitors are asked to confirm that the following information has been read and that it is accepted.
Due to legal restrictions, this part of the website of NextCell Pharma AB (publ) (the "Company") is not accessible to certain persons. We therefore ask you to read the following information and provide the following confirmation each time you wish to access these websites. Please note that the terms and conditions below may be changed or updated, and it is therefore important that you read them each time you visit this page.
The information contained in this section ofthe Company’s website is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States of America (including its territories and possessions, any state of the United States andthe District of Columbia, (the "United States")), Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Switzerland, Singapore, South Africa, South Korea or any jurisdiction where to do so might constitute aviolation of the local securities laws or regulations of such jurisdiction, or would require prospectus, registration or any other actions to be taken in addition to the requirements under Swedish law, and does not constitute anoffer to sell or the solicitation of an offer to buy or acquire, any shares orother securities of the Company to persons in the above-mentioned jurisdictions.
Any securities of the Company referred to on this website (the "Securities") have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within or to the United States absent registration or pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Actand in compliance with any applicable securities laws of any state or other jurisdiction of the United States.
The Securities have also not been and will also not be registered under the applicable securities laws of Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Switzerland, Singapore, South Africa or South Korea, and may therefore not be offered or sold in or into or for the account or benefit of any person having a registered address in, orlocated or resident in, Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Switzerland, Singapore, South Africa or South Korea.
Access to the information and documents contained on the following website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons residing outside of Sweden who wish to have access to the documents contained on this website should first ensure that they arenot subject to local laws or regulations that prohibit or restrict their right to access this website or require registration or approval for any acquisition of securities by them. No such registration or approval has been obtained outside Sweden. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.
We therefore ask you to confirm that you are resident and physically present outside the United States, Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Switzerland, Singapore, SouthAfrica, South Korea or any other jurisdiction where such action is wholly or partially subject to legal restrictions, or where such action would require additional prospectuses, registrations or other measures than what follows from Swedish law and are entitled to access the information on these websites without limitation by law or other rules and without the requirement that further measures need to be taken by the Company. We also ask you to confirm that youhave read the information, conditions and restrictions above and that you agree to comply with them.
